His persistence in biomedical technology and optimism about Sino-German cooperation and exchange in biomedical technology contributed to the establishment of Changjiang Biotechnology Consulting Company in Germany, focusing on China and Germany. As Dr. Bai Lin said at the annual meeting of China Society of Life Sciences and Biotechnology held in Berlin on October 20 10, 165438 10, biomedical technology is a core industry related to the whole human life and health, and it is also the fastest-growing high-tech field in the world today. As a traditional science and technology power, Germany has obvious advantages in the field of biomedicine, while China, as a new biomedical power, is facing practical problems such as technological upgrading and narrowing the gap with developed countries. Germany and China have many complementary factors in the field of biomedicine. Whether in scientific research and development, outsourcing projects or market development, Germany and China will be mutually beneficial in the field of biomedicine. Germany's biomedical industry will continue to maintain its position as a pillar industry and promote Germany's economic development and scientific and technological innovation. China biomedical science and technology industry will surely become a new leader in promoting the development of science and technology in China. China and Germany will have more and more comprehensive cooperation and exchanges in the field of life sciences in the near future, and the result will be win-win.